Quantcast

Latest AstraZeneca Stories

2014-09-20 23:02:18

LifeScienceIndustryResearch.com adds “Symbicort (Asthma) - Forecast and Market Analysis to 2023” to its store. Report provides Sales information covered for the US, France, Germany, Italy, Spain, the UK, Japan and Australia. Dallas, TX (PRWEB) September 20, 2014 New PharmaPoint Drug Evaluation report, “Symbicort (Asthma) – Forecast and Market Analysis to 2023″. The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious...

2014-09-19 16:24:14

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fg8h7p/global) has announced the addition of the "Global Endometriosis Market 2014-2018" [http://www.researchandmarkets.com/research/fg8h7p/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Endometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining...

2014-09-19 00:21:26

BASEL, Switzerland, Sept. 19, 2014 /PRNewswire/ -- -- Global network of over 3,500 farms established to measure productivity -- First independently-audited data to be published in March 2015 -- Projects underway in all regions; partnerships agreed and expanded Syngenta today provided an update on the progress of The Good Growth Plan one year after its launch in September 2013. The Plan comprises six measurable commitments for the year 2020 to help address the global food...

2014-09-16 12:31:25

SAN FRANCISCO, Sept. 16, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK((TM)) (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-09-15 08:26:00

The makers of FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) and the "CSI: Cyber" star launch national campaign to dispel common misconceptions about flu and annual vaccination WILMINGTON, Del., Sept. 15, 2014 /PRNewswire/ -- AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As...

2014-09-12 16:24:47

WASHINGTON, Sept. 12, 2014 /PRNewswire/ -- Syngenta today responded to the lawsuit filed against Syngenta Seeds, Inc. in Louisiana state court by Cargill. Syngenta believes that the lawsuit is without merit and strongly upholds the right of growers to have access to approved new technologies that can increase both their productivity and their profitability. The Agrisure Viptera(®) trait (MIR162) was approved for cultivation in the U.S. in 2010. Syngenta commercialized the trait...

2014-09-12 12:22:13

- "Right to Grow" program offers U.S. farmers corn rootworm control and a stewardship premium for Agrisure Duracade corn planted in 2015 MINNETONKA, Minn., Sept. 12, 2014 /PRNewswire/ -- Syngenta announced today that it has renewed and enhanced its program with Gavilon Grain, LLC, to provide grain marketing opportunities for U.S. farmers who plant Agrisure Duracade(TM) in 2015. Agrisure Duracade is Syngenta's cutting-edge corn rootworm (CRW) control technology approved in the U.S....

2014-09-11 23:02:32

New research report “Global Intranasal Drug Delivery Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London, UK (PRWEB) September 11, 2014 The emergence of intranasal drug delivery as an essential method of delivering drugs recently has been largely driven by its potential and capability to cure chronic allergies and local infections. The scientists and researchers have found out a variety of advantages and benefits of utilising...

2014-09-11 20:21:43

Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related